glp-1 pancreatic cancer peptide analogs for targeting beta cells Reassuring Data on GLP-1 RAs

People without diabetes typically notice smoother energy levels after meals

Discontinuing the medication is known to lead to rapid weight regain, creating a significant burden of having to take weekly injections throughout the treatment period

in a 5-year longitudinal cohort study found a stronger association, reporting that semaglutide exposure more than doubled the risk of NAION (91)

[DOI] [PMC free article] [PubMed] [Google Scholar] 65.Rouse R, Xu L, Stewart S, Zhang J

Compounded formulations may be considered only when clinically appropriate and legally permitted based on an individualized medical evaluation

These medications slow down how quickly your stomach empties, which can lead to feelings of fullness, bloating, and nausea